Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/47428
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOgura, Hiromu-
dc.contributor.authorHatip-Al-Khatib, İzzettin-
dc.contributor.authorSuenaga, Midori-
dc.contributor.authorBölükbaşı Hatip, Funda-
dc.contributor.authorMishima, Takayasu-
dc.contributor.authorFujioka, Shinsuke-
dc.contributor.authorOuma, Shinji-
dc.contributor.authorMatsunaga, Yoichi-
dc.contributor.authorTsuboi, Yoshio-
dc.date.accessioned2023-01-09T21:24:34Z-
dc.date.available2023-01-09T21:24:34Z-
dc.date.issued2021-
dc.identifier.issn2405-6502-
dc.identifier.urihttps://doi.org/10.1016/j.ensci.2021.100369-
dc.identifier.urihttps://hdl.handle.net/11499/47428-
dc.description.abstractBackground and purpose: There is sufficient evidence to support vitamin D's noncalcemic effects and the role of vitamin D deficiency in the development of a wide range of neurological disorders. This study aimed to evaluate whether serum 25(OH)D and 1,25(OH) 2 D could be used as biomarkers to differentiate between healthy subjects (HS), multiple system atrophy (MSA) and Parkinson's disease (PD) patients of both genders. Methods: A total of 107 subjects were included in this study, divided into three groups: 1- HS (n = 61), 2- MSA patients (n = 19), and 3- PD patients (n = 27). The patients were assessed using UMSARS II, UPDRS III, H&Y, MMSE and MoCA rating scales. The levels of 25(OH)D and 1,25(OH) 2 D in serum were determined using the radioimmunoassay technique. Results: The levels of 25(OH)D and 1,25(OH) 2 D in HS were 26.85 +/? 7.62 ng/mL and 53.63 +/? 13.66 pg/mL respectively. 25(OH)D levels were lower in both MSA and PD by 61% and 50%, respectively (P = 0.0001 vs. HS). 1,25(OH) 2 D levels were lower in MSA by 29%(P = 0.001 vs HS). There was a correlation between 25(OH)D and 1,25(OH) 2 D in MSA and PD, but not in HS. 1,25(OH) 2 D regressed with MMSE (? = 0.476, P = 0.04, R 2 = 0.226) in MSA, and with UPDRS III (? = ?0.432, P = 0.024, R 2 = 0.187) and MoCA (? = 0.582, P = 0.005,R 2 = 0.279) in PD. 25(OH)D displayed considerable differentiative strength between HS and MSA (Wald = 17.123, OR = 0.586, P = 0.0001; AUC = 0.982, sensitivity and Youden index = 0.882, P = 0.0001) and PD (Wald = 18.552, OR = 0.700, P = 0.0001; AUC = 0.943, sensitivity = 0.889, YI = 0.791, P = 0.0001). 1,25(OH) 2 D distinguished MSA from PD (Wald 16.178, OR = 1.117, P = 0.0001; AUC = 0.868, sensitivity = 0.926, Youden index =0.632, P = 0.0001). H&Y exhibited the highest sensitivity, AUC, and significant distinguishing power between MSA and PD. Conclusions: Serum 25(OH)D and 1,25(OH) 2 D could be useful biomarkers for MSA and PD. 25(OH)D and H&Y provided the highest sensitivity and group classification characteristics. © 2018en_US
dc.description.sponsorshipMinistry of Health, Labour and Welfare, MHLWen_US
dc.description.sponsorshipWe appreciate Assist. Prof. Hande Şenol's assistance with the statistical analysis. A grant-in-aid (No. 18 K 11009) from the Scientific Research and a grant-in-aid (No. 20FC 1049) from the Japanese Ministry of Health, Labor, and Welfare supported this research.en_US
dc.language.isoenen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofeNeurologicalScien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHoehn & Yahr staging scaleen_US
dc.subjectMultiple system atrophyen_US
dc.subjectParkinson's diseaseen_US
dc.subjectUnified MSA rating scaleen_US
dc.subjectUnified PD rating scaleen_US
dc.subjectVitamin Den_US
dc.subject25 hydroxyvitamin Den_US
dc.subjectcalcitriolen_US
dc.subjectadulten_US
dc.subjectageden_US
dc.subjectarea under the curveen_US
dc.subjectArticleen_US
dc.subjectclinical assessmenten_US
dc.subjectcontrolled studyen_US
dc.subjectdemographicsen_US
dc.subjectdiagnostic accuracyen_US
dc.subjectdisease durationen_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectmiddle ageden_US
dc.subjectMini Mental State Examinationen_US
dc.subjectParkinson diseaseen_US
dc.subjectpredictive valueen_US
dc.subjectradioimmunoassayen_US
dc.subjectrating scaleen_US
dc.subjectsensitivity and specificityen_US
dc.subjectsex differenceen_US
dc.subjectShy Drager syndromeen_US
dc.subjectUnified Parkinson Disease Rating Scaleen_US
dc.subjectvitamin blood levelen_US
dc.titleCirculatory 25(OH)D and 1,25(OH)2D as differential biomarkers between multiple system atrophy and Parkinson's disease patientsen_US
dc.typeArticleen_US
dc.identifier.volume25en_US
dc.identifier.doi10.1016/j.ensci.2021.100369-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid57189252974-
dc.authorscopusid57497291000-
dc.authorscopusid7101669080-
dc.authorscopusid8108285800-
dc.authorscopusid43761278400-
dc.authorscopusid41861403600-
dc.authorscopusid7801638078-
dc.identifier.scopus2-s2.0-85122672171en_US
dc.identifier.scopusqualityQ3-
item.openairetypeArticle-
item.grantfulltextopen-
item.languageiso639-1en-
item.fulltextWith Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
Files in This Item:
File SizeFormat 
1-s2.0-S2405650221000617-main.pdf1.06 MBAdobe PDFView/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

6
checked on Nov 23, 2024

Page view(s)

62
checked on Aug 24, 2024

Download(s)

26
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.